Sympathetic cardiac influence and arterial blood pressure instability

Kevin J. Formes, D. Walter Wray, Albert Yurvati, Martin S. Weiss, Xiangrong Shi

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Abstract

Previous studies have suggested that sympathetic cardiac blockade enhances baroreflex function, whereas parasympathetic blockade diminishes baroreflex sensitivity and elicits arterial blood pressure (ABP) instability. The aim of this project was to test the hypothesis that sympathetic cardiac blockade was beneficial in maintaining ABP stability during orthostatic challenge. In 8 young healthy subjects, measurements were taken before and after sympathetic cardiac blockade (β1-adrenoceptor blockade via metoprolol) in combination with or without parasympathetic blockade (atropine) at rest and during lower body negative pressure (LBNP). Arterial blood samples were obtained to evaluate plasma renin activity (PRA) and norepinephrine (NE). Power spectral analyses were performed on heart rate (HR) and ABP variability. LBNP -50 Torr significantly decreased systolic blood pressure (SBP, -6±3 mm Hg) and increased PRA (from 0.72±0.23 to 1.75±0.24 ng ml-1 h-1) and NE (from 1.02±0.11 to 2.13±0.32 pg ml -1). Low frequency (LF, 0.04-0.12 Hz) SBP and diastolic blood pressure (DBP) variability were significantly augmented by LBNP (4.1±1.6 vs. 10.8±3.0 mm Hg2, and 3.1±1.0 vs. 7.9±1.9 mm Hg2, respectively). Following metoprolol, arterial baroreflex sensitivity (assessed by the slope of HR interval to SBP during injection with 1 μg kg-1 phenylephrine) increased significantly (9.9±2.2 to 19.6±4.1 ms mm Hg-1). With β1-adrenoceptor blockade, LBNP still decreased SBP (-10±2 mm Hg) and increased NE, but did not significantly augment PRA (0.59±0.22 vs. 1.03±0.18 ng ml-1 h-1), or LF SBP and DBP variability (3.3±0.6 vs. 5.7±1.3 mm Hg2, and 3.1±0.7 vs. 5.4±1.1 mm Hg2, respectively). The increased PRA during LBNP remained non-significant following metoprolol combined with atropine, whereas the augmented LF SBP (2.6±0.7 vs. 9.9±2.8 mm Hg2) and DBP (2.5±0.7 vs. 11.1±3.0 mm Hg2) variability were significantly accentuated compared to both metoprolol alone and control conditions, accompanied by a greater ΔSBP (-17±7 mm Hg) and significantly diminished baroreflex gain (0.91±0.05 ms/mm Hg). These data suggested that removal of sympathetic cardiac influence improved cardiovascular stability as indicated by a diminished LF ABP variability, which was related to an enhanced cardiac responsiveness.

Original languageEnglish
Pages (from-to)116-124
Number of pages9
JournalAutonomic Neuroscience: Basic and Clinical
Volume118
Issue number1-2
DOIs
StatePublished - 31 Mar 2005

Fingerprint

Lower Body Negative Pressure
Arterial Pressure
Blood Pressure
Metoprolol
Baroreflex
Renin
Norepinephrine
Atropine
Adrenergic Receptors
Heart Rate
Phenylephrine
Healthy Volunteers
Injections

Keywords

  • Lower body negative pressure
  • Metoprolol
  • Plasma renin activity
  • Power spectral analysis
  • Vasomotion

Cite this

Formes, Kevin J. ; Wray, D. Walter ; Yurvati, Albert ; Weiss, Martin S. ; Shi, Xiangrong. / Sympathetic cardiac influence and arterial blood pressure instability. In: Autonomic Neuroscience: Basic and Clinical. 2005 ; Vol. 118, No. 1-2. pp. 116-124.
@article{508dd48b97704d4ba42bdefbc6e155df,
title = "Sympathetic cardiac influence and arterial blood pressure instability",
abstract = "Previous studies have suggested that sympathetic cardiac blockade enhances baroreflex function, whereas parasympathetic blockade diminishes baroreflex sensitivity and elicits arterial blood pressure (ABP) instability. The aim of this project was to test the hypothesis that sympathetic cardiac blockade was beneficial in maintaining ABP stability during orthostatic challenge. In 8 young healthy subjects, measurements were taken before and after sympathetic cardiac blockade (β1-adrenoceptor blockade via metoprolol) in combination with or without parasympathetic blockade (atropine) at rest and during lower body negative pressure (LBNP). Arterial blood samples were obtained to evaluate plasma renin activity (PRA) and norepinephrine (NE). Power spectral analyses were performed on heart rate (HR) and ABP variability. LBNP -50 Torr significantly decreased systolic blood pressure (SBP, -6±3 mm Hg) and increased PRA (from 0.72±0.23 to 1.75±0.24 ng ml-1 h-1) and NE (from 1.02±0.11 to 2.13±0.32 pg ml -1). Low frequency (LF, 0.04-0.12 Hz) SBP and diastolic blood pressure (DBP) variability were significantly augmented by LBNP (4.1±1.6 vs. 10.8±3.0 mm Hg2, and 3.1±1.0 vs. 7.9±1.9 mm Hg2, respectively). Following metoprolol, arterial baroreflex sensitivity (assessed by the slope of HR interval to SBP during injection with 1 μg kg-1 phenylephrine) increased significantly (9.9±2.2 to 19.6±4.1 ms mm Hg-1). With β1-adrenoceptor blockade, LBNP still decreased SBP (-10±2 mm Hg) and increased NE, but did not significantly augment PRA (0.59±0.22 vs. 1.03±0.18 ng ml-1 h-1), or LF SBP and DBP variability (3.3±0.6 vs. 5.7±1.3 mm Hg2, and 3.1±0.7 vs. 5.4±1.1 mm Hg2, respectively). The increased PRA during LBNP remained non-significant following metoprolol combined with atropine, whereas the augmented LF SBP (2.6±0.7 vs. 9.9±2.8 mm Hg2) and DBP (2.5±0.7 vs. 11.1±3.0 mm Hg2) variability were significantly accentuated compared to both metoprolol alone and control conditions, accompanied by a greater ΔSBP (-17±7 mm Hg) and significantly diminished baroreflex gain (0.91±0.05 ms/mm Hg). These data suggested that removal of sympathetic cardiac influence improved cardiovascular stability as indicated by a diminished LF ABP variability, which was related to an enhanced cardiac responsiveness.",
keywords = "Lower body negative pressure, Metoprolol, Plasma renin activity, Power spectral analysis, Vasomotion",
author = "Formes, {Kevin J.} and Wray, {D. Walter} and Albert Yurvati and Weiss, {Martin S.} and Xiangrong Shi",
year = "2005",
month = "3",
day = "31",
doi = "10.1016/j.autneu.2005.01.002",
language = "English",
volume = "118",
pages = "116--124",
journal = "Autonomic Neuroscience: Basic and Clinical",
issn = "1566-0702",
publisher = "Elsevier",
number = "1-2",

}

Sympathetic cardiac influence and arterial blood pressure instability. / Formes, Kevin J.; Wray, D. Walter; Yurvati, Albert; Weiss, Martin S.; Shi, Xiangrong.

In: Autonomic Neuroscience: Basic and Clinical, Vol. 118, No. 1-2, 31.03.2005, p. 116-124.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Sympathetic cardiac influence and arterial blood pressure instability

AU - Formes, Kevin J.

AU - Wray, D. Walter

AU - Yurvati, Albert

AU - Weiss, Martin S.

AU - Shi, Xiangrong

PY - 2005/3/31

Y1 - 2005/3/31

N2 - Previous studies have suggested that sympathetic cardiac blockade enhances baroreflex function, whereas parasympathetic blockade diminishes baroreflex sensitivity and elicits arterial blood pressure (ABP) instability. The aim of this project was to test the hypothesis that sympathetic cardiac blockade was beneficial in maintaining ABP stability during orthostatic challenge. In 8 young healthy subjects, measurements were taken before and after sympathetic cardiac blockade (β1-adrenoceptor blockade via metoprolol) in combination with or without parasympathetic blockade (atropine) at rest and during lower body negative pressure (LBNP). Arterial blood samples were obtained to evaluate plasma renin activity (PRA) and norepinephrine (NE). Power spectral analyses were performed on heart rate (HR) and ABP variability. LBNP -50 Torr significantly decreased systolic blood pressure (SBP, -6±3 mm Hg) and increased PRA (from 0.72±0.23 to 1.75±0.24 ng ml-1 h-1) and NE (from 1.02±0.11 to 2.13±0.32 pg ml -1). Low frequency (LF, 0.04-0.12 Hz) SBP and diastolic blood pressure (DBP) variability were significantly augmented by LBNP (4.1±1.6 vs. 10.8±3.0 mm Hg2, and 3.1±1.0 vs. 7.9±1.9 mm Hg2, respectively). Following metoprolol, arterial baroreflex sensitivity (assessed by the slope of HR interval to SBP during injection with 1 μg kg-1 phenylephrine) increased significantly (9.9±2.2 to 19.6±4.1 ms mm Hg-1). With β1-adrenoceptor blockade, LBNP still decreased SBP (-10±2 mm Hg) and increased NE, but did not significantly augment PRA (0.59±0.22 vs. 1.03±0.18 ng ml-1 h-1), or LF SBP and DBP variability (3.3±0.6 vs. 5.7±1.3 mm Hg2, and 3.1±0.7 vs. 5.4±1.1 mm Hg2, respectively). The increased PRA during LBNP remained non-significant following metoprolol combined with atropine, whereas the augmented LF SBP (2.6±0.7 vs. 9.9±2.8 mm Hg2) and DBP (2.5±0.7 vs. 11.1±3.0 mm Hg2) variability were significantly accentuated compared to both metoprolol alone and control conditions, accompanied by a greater ΔSBP (-17±7 mm Hg) and significantly diminished baroreflex gain (0.91±0.05 ms/mm Hg). These data suggested that removal of sympathetic cardiac influence improved cardiovascular stability as indicated by a diminished LF ABP variability, which was related to an enhanced cardiac responsiveness.

AB - Previous studies have suggested that sympathetic cardiac blockade enhances baroreflex function, whereas parasympathetic blockade diminishes baroreflex sensitivity and elicits arterial blood pressure (ABP) instability. The aim of this project was to test the hypothesis that sympathetic cardiac blockade was beneficial in maintaining ABP stability during orthostatic challenge. In 8 young healthy subjects, measurements were taken before and after sympathetic cardiac blockade (β1-adrenoceptor blockade via metoprolol) in combination with or without parasympathetic blockade (atropine) at rest and during lower body negative pressure (LBNP). Arterial blood samples were obtained to evaluate plasma renin activity (PRA) and norepinephrine (NE). Power spectral analyses were performed on heart rate (HR) and ABP variability. LBNP -50 Torr significantly decreased systolic blood pressure (SBP, -6±3 mm Hg) and increased PRA (from 0.72±0.23 to 1.75±0.24 ng ml-1 h-1) and NE (from 1.02±0.11 to 2.13±0.32 pg ml -1). Low frequency (LF, 0.04-0.12 Hz) SBP and diastolic blood pressure (DBP) variability were significantly augmented by LBNP (4.1±1.6 vs. 10.8±3.0 mm Hg2, and 3.1±1.0 vs. 7.9±1.9 mm Hg2, respectively). Following metoprolol, arterial baroreflex sensitivity (assessed by the slope of HR interval to SBP during injection with 1 μg kg-1 phenylephrine) increased significantly (9.9±2.2 to 19.6±4.1 ms mm Hg-1). With β1-adrenoceptor blockade, LBNP still decreased SBP (-10±2 mm Hg) and increased NE, but did not significantly augment PRA (0.59±0.22 vs. 1.03±0.18 ng ml-1 h-1), or LF SBP and DBP variability (3.3±0.6 vs. 5.7±1.3 mm Hg2, and 3.1±0.7 vs. 5.4±1.1 mm Hg2, respectively). The increased PRA during LBNP remained non-significant following metoprolol combined with atropine, whereas the augmented LF SBP (2.6±0.7 vs. 9.9±2.8 mm Hg2) and DBP (2.5±0.7 vs. 11.1±3.0 mm Hg2) variability were significantly accentuated compared to both metoprolol alone and control conditions, accompanied by a greater ΔSBP (-17±7 mm Hg) and significantly diminished baroreflex gain (0.91±0.05 ms/mm Hg). These data suggested that removal of sympathetic cardiac influence improved cardiovascular stability as indicated by a diminished LF ABP variability, which was related to an enhanced cardiac responsiveness.

KW - Lower body negative pressure

KW - Metoprolol

KW - Plasma renin activity

KW - Power spectral analysis

KW - Vasomotion

UR - http://www.scopus.com/inward/record.url?scp=15944383699&partnerID=8YFLogxK

U2 - 10.1016/j.autneu.2005.01.002

DO - 10.1016/j.autneu.2005.01.002

M3 - Article

VL - 118

SP - 116

EP - 124

JO - Autonomic Neuroscience: Basic and Clinical

JF - Autonomic Neuroscience: Basic and Clinical

SN - 1566-0702

IS - 1-2

ER -